Latest Direct To Consumer Sales News

Aristocrat Leisure has delivered a robust FY25 performance with double-digit growth in earnings and revenue, underpinned by market share gains and strategic portfolio realignment. The company also returned $1.4 billion to shareholders through dividends and buy-backs.

Lark Distilling Co. reported a 10% increase in net sales for Q1 FY26, driven by strong domestic and Asian export growth, while preparing for a major brand restage and leadership change.

ECS Botanics reports a positive cash flow milestone in Q1 FY26, driven by strong direct-to-consumer sales and operational efficiencies, while preparing for a European market debut.

The Calmer Co (ASX – CCO) reported an impressive $8 million revenue for FY25, marking 86% year-over-year growth and positioning itself as a global leader in the emerging kava market. With expanding retail presence and strong US sales, the company is on track to break even in 2026.

KMD Brands reported a modest 1% sales increase in FY25 but faced a sharp 65% drop in underlying EBITDA, prompting a bold 'Next Level' turnaround strategy targeting margin expansion and debt reduction in FY26.

Universal Store Holdings Limited reported a robust FY25 with sales rising 15.5% to $333.3 million and underlying EBIT up 15.9%, driven by strong performances across its retail brands and disciplined cost management.

Atomos Limited faced a challenging Q4 FY25 with US tariff disruptions but rebounded strongly in June, launching new products and appointing Peter Barber as CEO to drive future growth.

ECS Botanics reports a 20% quarterly surge in direct-to-consumer sales and a record medicinal cannabis harvest, supported by an expanded loan facility to fuel further growth.

The Calmer Co. International Limited has reported a striking 86% revenue jump to over AU$8 million in FY25, propelled by diversified sales channels and a strategic US expansion highlighted by new flavoured kava shots launched exclusively on Amazon USA.

OMG Group Limited has reported record monthly sales of $602,000 in June 2025, driven by surging ecommerce demand and strong operational cashflow, positioning the company for continued growth in FY26.

EZZ Life Science has launched its US-focused brand EZZDAY with four FDA-registered supplements, marking a major step in its international growth strategy. The company has also begun US-based manufacturing and opened an online store to target American consumers.

KMD Brands reports mixed sales across its portfolio with a notable rebound in Kathmandu’s direct-to-consumer sales and robust online growth, while managing tariff uncertainties and margin pressures.